About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

HRS-7535

Company: Shandong Suncadia Medicine Co., Ltd.
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 25, 2026

Trial details

Recruiting NCT NCT06820099

Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity

Not yet reported Shandong Suncadia Medicine Co., Ltd. 225 participants Est. completion 2026-12 1 site Stand-alone

Heart failure
View official trial listing →
Recruiting NCT NCT07528027

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Not yet reported Shandong Suncadia Medicine Co., Ltd. 648 participants Est. completion 2028-01 2 sites Stand-alone

Other conditions: Hypertension With Overweight or Obesity
View official trial listing →
Status unknown NCT NCT05347758

A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects

Not yet reported Shandong Suncadia Medicine Co., Ltd. 106 participants Est. completion 2023-03-15 Stand-alone

Other conditions: Healthy Subjects
View official trial listing →
Status unknown NCT NCT05759897

A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

Not yet reported Shandong Suncadia Medicine Co., Ltd. 180 participants Est. completion 2024-01-04 Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06132204

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2024-03-13 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06250946

Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

Not yet reported Shandong Suncadia Medicine Co., Ltd. 235 participants Est. completion 2025-01-22 1 site Stand-alone

Other conditions: Overweight and Obesity
View official trial listing →
Completed NCT NCT06393348

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

Not yet reported Shandong Suncadia Medicine Co., Ltd. 155 participants Est. completion 2025-03-13 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06415214

Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

Not yet reported Shandong Suncadia Medicine Co., Ltd. 281 participants Est. completion 2025-07-25 1 site Stand-alone

Type 2 diabetesChronic kidney disease
View official trial listing →
Completed NCT NCT06422039

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

Not yet reported Shandong Suncadia Medicine Co., Ltd. 24 participants Est. completion 2024-08-06 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06495931

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

Not yet reported Shandong Suncadia Medicine Co., Ltd. 24 participants Est. completion 2024-08-13 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06589765

A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Not yet reported Shandong Suncadia Medicine Co., Ltd. 810 participants Est. completion 2026-05-29 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06621316

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Not yet reported, Not yet reported Shandong Suncadia Medicine Co., Ltd. 74 participants Est. completion 2025-07-14 1 site Stand-alone

Other conditions: Overweight or Obesity
View official trial listing →
Completed NCT NCT06671821

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

Not yet reported Shandong Suncadia Medicine Co., Ltd. 81 participants Est. completion 2025-09-28 1 site Stand-alone

Other conditions: Chronic Weight Management
View official trial listing →
Completed NCT NCT06672172

A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Not yet reported Shandong Suncadia Medicine Co., Ltd. 284 participants Est. completion 2026-04-17 1 site Stand-alone

Type 2 diabetes
View official trial listing →
Completed NCT NCT06727838

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

Not yet reported Shandong Suncadia Medicine Co., Ltd. 18 participants Est. completion 2025-01-25 1 site Stand-alone

Other conditions: Diabetes
View official trial listing →
Completed NCT NCT06819488

A Clinical Study of Mass Balance of [14C]HRS-7535

Not yet reported Shandong Suncadia Medicine Co., Ltd. 6 participants Est. completion 2025-04-16 1 site Stand-alone

Type 2 diabetes Other conditions: Weight Loss
View official trial listing →
Completed NCT NCT06904105

A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

Not yet reported Shandong Suncadia Medicine Co., Ltd. 556 participants Est. completion 2026-06-12 1 site Stand-alone

Other conditions: Overweight, Obesity
View official trial listing →
Completed NCT NCT06961643

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

Not yet reported Shandong Suncadia Medicine Co., Ltd. 24 participants Est. completion 2026-01-22 1 site Stand-alone

Other conditions: Diabetes Mellitus
View official trial listing →
Completed NCT NCT07269756

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

Not yet reported Shandong Suncadia Medicine Co., Ltd. 40 participants Est. completion 2026-03-08 1 site Stand-alone

Other conditions: Obesity, Overweight
View official trial listing →
Not yet recruiting NCT NCT07625774

Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease

Not yet reported Shandong Suncadia Medicine Co., Ltd. 3690 participants Est. completion 2031-07 2 sites Stand-alone

Chronic kidney disease
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT07528027

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.